Prempro
Product Images NDC 54868-5047

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Prempro (NDC 54868-5047). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (0.625 mg / 2.5 mg)

Packaging label for Prempro 0.625/2.5 mg, 28 tablets. The label shows distribution by Physicians Total Care, Tulsa, OK, and includes lot number 0000 and expiration date 01/60. The manufacturer is Wyeth Pharmaceuticals Inc., Philadelphia, PA. A barcode is also present on the label.*

FDA Label Image

Principal Display Panel (0.45 mg / 1.5 mg)

Prempro Low 0.45mg/1.5mg medication label distributed by Physicians Total Care, Inc. The label includes lot number 000, expiration date 01/60, and a barcode. The product is manufactured by Wyeth Pharmaceuticals Inc., Philadelphia, PA.*

FDA Label Image

Principal Display Panel (0.3 mg / 1.5 mg)

Prempro 0.3/1.5 mg label with lot number and expiration date. The label includes the distributor Physicians Total Care, Tulsa, OK, and the manufacturer Wyeth Pharmaceuticals, Philadelphia, PA. A barcode and NDC number 54868-5047-0 are also visible.*

FDA Label Image

Computer_13.jpg (Computer)

FDA Label Image

Pfizer-logo-black.jpg (Pfizer Logo Black)

FDA Label Image

Phone_7.jpg (Phone)

FDA Label Image

Chemical Structure (Prempro Premphase 01)

Chemical structure diagram showing the molecular arrangement of the active ingredient in Prempro, a pharmaceutical product by Physicians Total Care, Inc.*

FDA Label Image

Figure 1 (Prempro Premphase 02)

A line graph comparing the percentage of patients over 13 cycles for two different treatment groups labeled CE/MPA with distinct dose regimens. The x-axis represents the treatment cycle number from 1 to 13, and the y-axis shows the percentage of patients ranging from 10% to 100%. Two lines depict patient percentage trends over time for each dosage group.*

FDA Label Image

Figure 2 (Prempro Premphase 03)

A line graph depicting the percentage of patients over 13 cycles, grouped by three dosage categories labeled CE/MPA: 0.625/2.5, 0.45/1.5, and 0.3/1.5. The y-axis shows the percentage of patients from 0 to 100, and the x-axis represents the cycle number from 1 to 13. Each dosage group is tracked with distinct markers and lines showing an increasing trend in patient percentages across cycles.*

FDA Label Image

Figure 3 (Prempro Premphase 04)

A cumulative distribution plot showing the percent change from baseline in spine bone mineral density (BMD) on the x-axis and cumulative percent of subjects on the y-axis. The graph compares data for Prempro and placebo groups, with different curves representing various dosage levels.*

FDA Label Image

Figure 4 (Prempro Premphase 05)

A line graph showing the adjusted percent change from baseline over multiple cycles for different doses, including 0.625/2.5, 0.45/1.5, 0.3/1.5, and placebo. The x-axis represents cycles, and the y-axis represents percent change. Each dose group is marked with distinct symbols and sample sizes are indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.